We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastic injection? Identification and quantification of plastic particles in medical injections
Summary
Scientists discovered that medical injection solutions (saline and glucose) sold in China contain an average of 895 microplastic particles per kilogram, with some samples reaching 1,840 particles. Unlike microplastics ingested through food, these particles enter the bloodstream directly through IV injection, bypassing the body's digestive barriers. This reveals a previously unrecognized pathway for microplastic exposure that could pose unique health risks for hospitalized patients.
Microplastics (MPs) mainly enter the human body through ingestion and breathing. Most of them are excreted through feces, and only a small amount can accumulate in human organs and tissues. In contrast, if intravenous injection contains MPs, it could directly enter bloodstream and maybe pose severe health risk. To verify this hypothesis, we collected two types of injection [0.9 % NaCl and 5 % Glucose] with three dominant brands in China, to analyze the possible MPs. The results indicated that the injection had an average abundance of 895 MP particles/kg, ranging from 140 to 1840 particles/kg. Furthermore, more MPs were found in NaCl than Glucose injection. The MPs encompassed 21 types of polymers with notable brand variations in distribution. Notably, polyisoprene chlorinated (61.77 % in NaCl, 61.23 % in Glucose) are most prevalent. Most polymers had small diameter, with 30.5 % and 44.2 % of particles measuring between 0 and 30 μm in NaCl and Glucose injection, respectively. These minute particle sizes contribute to the dispersal of MPs within human tissues. In terms of shape, most polymers are fibers/fragments, with some in bead form. Our study uncovered a previously unnoticed but important pathway for MPs enter the human body, emphasizing the need to evaluate health risks of infusion-related MP.
Sign in to start a discussion.
More Papers Like This
Identification and quantification of micro–nano-plastics in polypropylene-bottled injections
Researchers examined 16 batches of intravenous (IV) fluids packaged in polypropylene plastic bottles and found microplastic and nanoplastic particles in all of them, with concentrations reaching up to 10 million particles per milliliter. This is the first study to confirm that patients receiving IV infusions are being directly exposed to microplastics entering their bloodstream, though whether this causes harm remains to be studied.
Hidden hazards: microplastics in intravenous admixtures and their path into the body
This study investigated microplastic contamination in intravenous (IV) fluid bags used in hospitals, finding that prolonged storage in plastic containers leads to microplastic particles leaching into the solution. This means patients receiving IV treatments may be exposed to microplastics that enter the bloodstream directly, bypassing the body's natural barriers. The findings highlight an overlooked route of microplastic exposure in medical settings that needs further investigation.
Health Risks from Microplastics in Intravenous Infusions: Evidence from Italy, Spain, and Ecuador
Researchers analyzed intravenous (IV) fluid bags and bottles from Italy, Spain, and Ecuador and found microplastics in nearly all samples, with plastic bags containing up to 299 particles per liter. This is concerning because IV fluids deliver microplastics directly into the bloodstream, bypassing the body's natural barriers, and some brands showed concentrations high enough to pose clinical risk.
Intravenous hypertonic fluids as a source of human microplastic exposure
Researchers tested 13 brands of intravenous hypertonic fluid solutions and found microplastics in every single sample, with an average of about 63 particles per liter. The particles were mostly fragments of various plastics ranging from 0.04 to 2.37 millimeters in size. This is especially concerning because IV fluids bypass the body's natural barriers like the gut and lungs, delivering microplastics directly into the bloodstream of hospital patients.
Micro(nano)plastics (< 4 μm): An important but ignored concern during intravenous infusion
Researchers found that common IV bags, tubes, and syringes release thousands of tiny plastic particles directly into the bloodstream during routine medical treatments. The particles, smaller than 4 micrometers, included types like PVC and polypropylene and were found in nearly all tested infusion products. This is a significant finding because it identifies a previously overlooked source of microplastic exposure that bypasses the body's natural barriers entirely.